Endothelial dysfunction is highly prevalent in heart failure with preserved ejection fraction, but experimental evidence demonstrating its causal role in the pathophysiology of the disease remains incomplete.
This review summarizes the evidence supporting the causal role of endothelial dysfunction and coronary microvascular dysfunction in the pathophysiology of HFpEF.
Heart failure with preserved ejection fraction (HFpEF) has been recognized as the greatest single unmet need in cardiovascular medicine. Indeed, the morbi-mortality of HFpEF is high and as the population ages and the comorbidities increase, so considerably does the prevalence of HFpEF. However, HFpEF pathophysiology is still poorly understood and therapeutic targets are missing. An unifying, but untested, theory of the pathophysiology of HFpEF, proposed in 2013, suggests that cardiovascular risk factors lead to a systemic inflammation, which triggers endothelial cells (EC) and coronary microvascular dysfunction. This cardiac small vessel disease is proposed to be responsible for cardiac wall stiffening and diastolic dysfunction. This paradigm is based on the fact that microvascular dysfunction is highly prevalent in HFpEF patients. More specifically, HFpEF patients have been shown to have decreased cardiac microvascular density, systemic endothelial dysfunction and a lower mean coronary flow reserve. Importantly, impaired coronary microvascular function has been associated with the severity of HF. This review discusses evidence supporting the causal role of endothelial dysfunction in the pathophysiology of HFpEF in human and experimental models.
Cornuault et al. (Fri,) conducted a review in Heart failure with preserved ejection fraction (HFpEF). Endothelial dysfunction is highly prevalent in heart failure with preserved ejection fraction, but experimental evidence demonstrating its causal role in the pathophysiology of the disease remains incomplete.